Non-pharmacological treatments for pain relief are more and more used in clinical care although any scientific validation. Among the non-pharmacological treatments of neuropathic pain relief, TENS (Electrical Nerve Stimulation Therapy) is the major treatment with the best benefit. Unfortunately, the use of TENS by patients appears very difficult. Because of this inconvenience, more than 40% of TENS users interrupt the treatment despite treatment benefit. A new TENS device: actiTENS that seems to be less constraining than TENS is now available in France. ActiTENS efficacy and safety compared to TENS need to be investigated. The main objective is to evaluate and to compare the use of actiTENS, with TENS Eco 2, the classical device in patients with chronic neuropathic pain.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Enrollment
72
TENS Eco2 or actiTENS, both admitted and reimbursed in FRANCE according to regulation
CHU Amiens Picardie
Amiens, France
CHD La Roche Sur Yon
La Roche-sur-Yon, France
CHU de Nantes
Nantes, France
APHP - Hopital Saint Antoine
Paris, France
CHU de Toulouse
Toulouse, France
Disconfort of using TENS (Electrical Nerve Stimulation Therapy) Eco2 versus actiTENS
Discomfort evaluation will be determined by using VAS (Visual Analogue Scale)
Time frame: day7 after patient inclusion
Disconfort of using TENS (Electrical Nerve Stimulation Therapy) Eco2 versus actiTENS
Discomfort evaluation will be determined by using VAS (Visual Analogue Scale)
Time frame: day 35 after patient inclusion
length of TENS daily use
Length of TENS daily use
Time frame: day7 after patient inclusion
length of TENS daily use
Length of TENS daily use
Time frame: day 35 after patient inclusion
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.